期刊文献+

系统性红斑狼疮患者骨髓增生异常性改变 被引量:1

下载PDF
导出
摘要 目的评价系统性红斑狼疮(SLE)患者骨髓增生异常的特性及其与疾病活动度的关系。方法SLE初次诊治患者48例,骨髓增生异常综合征(myelodysplastic syndrome,MDS)患者10例,免疫性血小板减少性紫癜(idiopathic thrombocytopenic purpura,ITP)患者10例。所有患者都因血细胞减少予骨髓穿刺。骨髓涂片Wright-Gimsa染色后在显微镜下观察,同时对比观察10例MDS和ITP患者的骨髓,评价骨髓增生异常的情况。临床和实验室资料通过病历记载获得,SLE疾病的活动性根据SLEDAI标准评估。结果48例SLE患者中白细胞减少12例,贫血43例,血小板减少28例,Coombs’试验阳性17例。31例患者有骨髓发育异常,以派-胡畸形最常见,还有红系和巨核细胞系发育异常。而10例MDS患者至少可以发现一系的病态造血。而ITP患者只是巨核细胞明显增多,出现幼稚产血小板巨核细胞,而粒系和红系没有病态造血。骨髓病态造血的出现和SLE活动明显相关,5例有狼疮性肾炎的患者骨髓均有病态造血。15例复查骨髓的患者中,12例疾病控制良好的患者骨髓病态造血消失。结论血细胞减少是SLE常见的表现,骨髓的各系包括粒系、红系和巨核细胞系均可以有病态造血,疾病控制后病态造血可消失。SLE患者骨髓的病态造血和SLE的严重性相关,可作为评价SLE活动性的指标。同时,对没有染色体异常的骨髓病态造血,诊断MDS时需排除SLE。
出处 《广东医学》 CAS CSCD 北大核心 2009年第10期1530-1531,共2页 Guangdong Medical Journal
  • 相关文献

参考文献8

  • 1陈嘉林,黄晓明,曾学军,王玉,周明晓,马亚辉,李蓉生,沈悌.系统性红斑狼疮患者血液学异常的特点及其临床意义[J].中华医学杂志,2007,87(19):1330-1333. 被引量:19
  • 2BEYAN E, BEYAN C, TURAN M. Hematological presentation in systemic lupus erythematosus and its relationship with disease activity[J]. Hematology, 2007, 12(3) : 257 -261.
  • 3VOULGARELIS M, GIANNOULI S, TASIDOU A, et al. Bone marrow histological findings in systemic lupus erythematosus with hematologic abnormalities : a clinicopathological study [J]. Am J Hematol, 2006, 81 (8) : 590 - 597.
  • 4YARALI N, DURU F, SIPAHI T, et al. Parvovirus B19 infection reminiscent of myelodysplastic syndrome in three children with chronic hemolytic anemia [ J ]. Pediatr Hematol Oncol, 2000, 17 (6) : 475 - 482.
  • 5MICHAEL S R, VURAL I L, BASSEN F A, et al. The hematologicaspcts of disseminated ( systemic ) lupus erythematosus [ J ]. Blood, 1951,6(11):1 059- 1 072.
  • 6BURKHARDT R. The bone marrow in systemic lupus erythematosus[J]. Semin Hematol, 1965, 2(1) : 29 -46.
  • 7FENG C S, NG M H, SZETO R S, et al. Bone marrow findings in lupus patients with pancytopenia[J]. Pathology, 1991,23( 1): 5 -7.
  • 8BAILEY F A, LILLY M, BERTOLI L F, et al. An antibody that inhibits in vitro bone marrow proliferation in a patient with systemic lupus erythematosus and aplastic anemia [J]. Arthritis Rheum, 1989, 32 (7) : 901 -905.

二级参考文献14

  • 1陈嘉林,李淑兰,徐闽,王海滨,葛昌文,李蓉生.血清转铁蛋白受体对贫血患者鉴别诊断的临床意义[J].中华内科杂志,2004,43(6):423-425. 被引量:12
  • 2李蓉生.慢性病贫血//张之南,沈悌,主编.血液病诊断及疗效标准.2版.北京:科学出版社,1998:30-33.
  • 3Font J, Cervera R, Ramos-Casals M, et al. Clusters of Clinical and Features in Systemic lupus erythematosus: Analysis of 600 patients from a single center. Semin Arthritis Rheum, 2004,33: 217 -230.
  • 4Hoohberg MC, Boyd RE , Ahearn JM, et al. Systemic lupus erythematosus : a review of Clinico-laboratory feature and immunogenetic markers in 150 patients with emphasis on demographic subets . Medicine, 1985,64:285-295.
  • 5Voulgarelis M, Kokori SIG, Ioannidis JAP, et al. Anaemia in systemic lupus erythematosus: aetiological profile and the role of erythropoietin. Ann Rheum Dis, 2000, 59: 217-222.
  • 6Keeling DM, Isonberg DA. Hematological manifestations of systemic lupus erythematosus. Blood Reviews, 1993, 7: 199- 207.
  • 7Pistiner M ,Wallace DJ ,Nessim S,et al. Lupus erythematosus in the 1980s: a Survey of 570 patients . Semin Arthritis Rheum, 1991, 21:55-64.
  • 8Kasitanon N, Magder LS, Petri M. Predictors of survival in systemic lupus erythematosus. Medicine, 2006, 85:147-156.
  • 9Matsugama W, Yamamoto M, Higashimoto I, et al. TNF-related apoptosis-inducing ligand is involved in neutropenia of systemic lupus erythematosus. Blood, 2004,104 : 184-191.
  • 10Chen M ,Zhao M H,Zhang Y,et al. Antineutrophil autoantibodies and their target antigens in systemic lupus erythematosus. Lupus, 2004, 13:584-589.

共引文献18

同被引文献5

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部